BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Innovations for Substance Use Disorders - ECPv6.15.17//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://i4sud.com
X-WR-CALDESC:Events for Innovations for Substance Use Disorders
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20240321T120000
DTEND;TZID=America/Los_Angeles:20240321T130000
DTSTAMP:20260526T162021
CREATED:20250204T044515Z
LAST-MODIFIED:20250204T225208Z
UID:2746-1711022400-1711026000@i4sud.com
SUMMARY:Xylazine: Where are the Market Gaps?
DESCRIPTION:The veterinary tranquilizer xylazine is being associated with a rising count of overdose fatalities across the country amidst the ongoing crisis of drug addiction and overdose. Persons are often exposed to xylazine unintentionally through adulterated heroin/fentanyl products. Data on this important public health threat are just emerging and suggest that xylazine exposure changes the experience of fentanyl and may lead to medical consequences such as skin ulcers. There exist pressing gaps in surveillance and medical treatment of xylazine\, which Dr. Kelly Dunn will explore in this webinar\, focusing on areas where inventive solutions are urgently required.
URL:https://i4sud.com/event/xylazine-where-are-the-market-gaps/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20240425T120000
DTEND;TZID=America/Los_Angeles:20240425T130000
DTSTAMP:20260526T162021
CREATED:20250204T044355Z
LAST-MODIFIED:20250204T225226Z
UID:2744-1714046400-1714050000@i4sud.com
SUMMARY:Elements of a Commercialization Plan: A Primer
DESCRIPTION:Join us for an insightful webinar where entrepreneurship expert Dr. Phil Phan will delve into the essential components necessary for a successful commercialization plan. If you are an academic researcher and have thought about making an impact using your innovative solutions\, join us to learn how to navigate the complexities of bringing a product to market. From market analysis to distribution channels and funding strategies to marketing tactics\, Dr. Phan will provide invaluable insights and practical tips to help you navigate the path to commercial success. At the end\, he will discuss the Innovations for Substance Use Disorders (I4SUD) program which can help you bring these ideas and innovations to life!
URL:https://i4sud.com/event/elements-of-a-commercialization-plan-a-primer/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20240523T120000
DTEND;TZID=America/Los_Angeles:20240523T130000
DTSTAMP:20260526T162021
CREATED:20250204T044246Z
LAST-MODIFIED:20250204T225238Z
UID:2742-1716465600-1716469200@i4sud.com
SUMMARY:A Personalized Virtual Reality Environment Tool to Mitigate Opioid Use Disorder
DESCRIPTION:Join I4SUD Alum and NIH $100K Challenge Winner\, Dr. Lola Akintola to hear about her project and her experience with I4SUD\nRegister
URL:https://i4sud.com/event/a-personalized-virtual-reality-environment-tool-to-mitigate-opioid-use-disorder/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260428T120000
DTEND;TZID=America/New_York:20260428T130000
DTSTAMP:20260526T162021
CREATED:20260413T142714Z
LAST-MODIFIED:20260413T143240Z
UID:3629-1777377600-1777381200@i4sud.com
SUMMARY:From Unstructured Notes to Actionable Insights: LLMs for Medical Cannabis Data Extraction
DESCRIPTION:Talk description \nMedicinal cannabis use is widespread but poorly captured in electronic health records and rarely structured enough to support research. This talk will present our efforts to address that gap by applying large language models to millions of clinical notes\, extracting structured data on cannabis use patterns\, indications\, and outcomes. The focus will be on the translational potential of this approach: how AI tools can convert an underutilized clinical data source into a research-ready dataset capable of supporting observational studies\, and to ultimately inform cannabis policy and improve patient care. \nJohannes Thrul \nJohannes Thrul\, PhD\, is an Associate Professor in the Department of Mental Health at the Johns Hopkins Bloomberg School of Public Health and has a joint appointment at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He received his PhD in Psychology from the Friedrich-Alexander University Erlangen-Nuremberg and completed postdoctoral training at UCSF. His research focuses on substance use and addiction\, as well as digital and mobile health research\, including the use of smartphone-based ecological momentary assessment and just-in-time interventions. He leads multiple NIH-funded studies and co-directs a national longitudinal research registry to examine the health effects of medicinal cannabis. He has received numerous teaching awards at Johns Hopkins and serves in editorial and scientific advisory roles across the addiction and digital health fields.
URL:https://i4sud.com/event/from-unstructured-notes-to-actionable-insights-llms-for-medical-cannabis-data-extraction/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260512T120000
DTEND;TZID=America/Los_Angeles:20260512T130000
DTSTAMP:20260526T162021
CREATED:20260427T161711Z
LAST-MODIFIED:20260507T105609Z
UID:3634-1778587200-1778590800@i4sud.com
SUMMARY:From Discovery to Impact: Advancing Therapeutics for Substance Use Disorders
DESCRIPTION:Talk Description \nThis presentation will outline the mission\, structure\, and impact of the Division of Therapeutics and Medical Consequences (DTMC)\, established in response to a 1989 Congressional mandate to advance medication development for substance use disorders (SUDs). It will describe how DTMC\, modeled after a virtual pharmaceutical company\, supports all phases of therapeutic development—from discovery through regulatory approval—to improve the management of SUDs and their medical consequences\, including HIV. The presentation will highlight DTMC’s strategic focus on developing safe and effective medications\, biologics\, devices\, digital therapeutics\, and behavioral therapies; its collaborations with industry and federal partners; its regulatory engagement with the FDA; and its record of notable contributions to advancing the treatment for opioid\, stimulant\, cannabis\, and nicotine use disorders. The presentation will include opportunities for collaborations with DTMC and funding opportunities to conduct research in this therapeutic development for SUDs. \nDavid White\, Ph.D. \nDr. David White is the Associate Director of the Division of Therapeutics and Medical Consequences (DTMC) and Chief of the Medications Discovery and Toxicology Branch at the National Institute on Drug Abuse (NIDA). In these roles\, he oversees DTMC’s preclinical medication discovery and safety assessment efforts for novel pharmacological treatments for substance use disorders. He also coordinates DTMC’s medications development contract program\, serves as the Division’s pharmaceutical liaison\, and leads DTMC’s business development activities. \nDr. White brings more than two decades of leadership experience at NIDA\, including service as Director of the Addiction Treatment Discovery Program from 2009 to 2023. Prior to joining NIDA in 2006\, he conducted substance use disorder–related research as a research faculty member and postdoctoral fellow in the Department of Pharmacology at Emory University School of Medicine\, where he authored numerous peer-reviewed publications. He earned a Ph.D. in neuropharmacology from West Virginia University School of Medicine in 1999 and a B.A. in biology from West Virginia University in 1994.
URL:https://i4sud.com/event/from-discovery-to-impact-advancing-therapeutics-for-substance-use-disorders/
END:VEVENT
END:VCALENDAR